Meta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hours.

Journal of managed care pharmacy : JMCP

Volumn 9, Issue 1, 2003, Pages 45-52

  Adelman, James U ^a   Belsey, Jonathan ^a  

^a Headache Wellness Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIZATRIPTAN; SEROTONIN AGONIST; SUMATRIPTAN; TRIAZOLE DERIVATIVE; TRYPTAMINE DERIVATIVE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; DOSE RESPONSE; ECONOMICS; FEMALE; HUMAN; MALE; META ANALYSIS; MIGRAINE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; RANDOMIZED CONTROLLED TRIALS; SEROTONIN AGONISTS; SUMATRIPTAN; TRIAZOLES; TRYPTAMINES;

EID: 0642378215     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2003.9.1.45     Document Type: Article

References (0)